Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Acute Methamphetamine-Induced Hepatic and Pancreatic Ischemia.

Merchant K, Schammel C, Fulcher J.

Am J Forensic Med Pathol. 2019 Apr 24. doi: 10.1097/PAF.0000000000000486. [Epub ahead of print]

PMID:
31033491
2.

Left ventricular cardiac geometry and ambulatory blood pressure in children.

Shilly S, Merchant K, Singer P, Frank R, Gurusinghe S, Infante L, Sethna CB.

J Clin Hypertens (Greenwich). 2019 May;21(5):566-571. doi: 10.1111/jch.13540. Epub 2019 Apr 13.

3.

Paediatric tele-emergency care: A study of two delivery models.

Weigel PA, Merchant KA, Wittrock A, Kissee J, Ullrich F, Bell AL, Marcin J, M Ward M.

J Telemed Telecare. 2019 Apr 9:1357633X19839610. doi: 10.1177/1357633X19839610. [Epub ahead of print]

PMID:
30966860
4.

A germline variant of TP53 in paediatric diffuse leptomeningeal glioneuronal tumour.

Tan GIL, Merchant K, Tan EEK, Low DCY, Ng LP, Seow WT, Low SYY.

Childs Nerv Syst. 2019 Jun;35(6):1021-1027. doi: 10.1007/s00381-019-04128-w. Epub 2019 Apr 2.

PMID:
30937530
5.

Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI).

Prakash N, Caspell-Garcia C, Coffey C, Siderowf A, Tanner CM, Kieburtz K, Mollenhauer B, Galasko D, Merchant K, Foroud T, Chahine LM, Weintraub D, Casaceli C, Dorsey R, Wilson R, Herzog M, Daegele N, Arnedo V, Frasier M, Sherer T, Marek K, Frank S, Jennings D, Simuni T; Parkinson's Progression Markers InitiativeSteering Committee; Study Cores; Site Investigators; Coordinators; Industry and Scientific Advisory Board.

Parkinsonism Relat Disord. 2019 May;62:201-209. doi: 10.1016/j.parkreldis.2018.12.025. Epub 2019 Jan 31.

PMID:
30738748
6.

Use Of Telemedicine For ED Physician Coverage In Critical Access Hospitals Increased After CMS Policy Clarification.

Ward MM, Merchant KAS, Carter KD, Zhu X, Ullrich F, Wittrock A, Bell A.

Health Aff (Millwood). 2018 Dec;37(12):2037-2044. doi: 10.1377/hlthaff.2018.05103.

PMID:
30633684
7.

Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model.

Wang H, Li Y, Ryder JW, Hole JT, Ebert PJ, Airey DC, Qian HR, Logsdon B, Fisher A, Ahmed Z, Murray TK, Cavallini A, Bose S, Eastwood BJ, Collier DA, Dage JL, Miller BB, Merchant KM, O'Neill MJ, Demattos RB.

Mol Neurodegener. 2018 Dec 17;13(1):65. doi: 10.1186/s13024-018-0296-y.

8.

A Proposed Roadmap for Parkinson's Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein.

Merchant KM, Cedarbaum JM, Brundin P, Dave KD, Eberling J, Espay AJ, Hutten SJ, Javidnia M, Luthman J, Maetzler W, Menalled L, Reimer AN, Stoessl AJ, Weiner DM; and The Michael J. Fox Foundation Alpha Synuclein Clinical Path Working Group.

J Parkinsons Dis. 2019;9(1):31-61. doi: 10.3233/JPD-181471.

9.

Finding useful biomarkers for Parkinson's disease.

Chen-Plotkin AS, Albin R, Alcalay R, Babcock D, Bajaj V, Bowman D, Buko A, Cedarbaum J, Chelsky D, Cookson MR, Dawson TM, Dewey R, Foroud T, Frasier M, German D, Gwinn K, Huang X, Kopil C, Kremer T, Lasch S, Marek K, Marto JA, Merchant K, Mollenhauer B, Naito A, Potashkin J, Reimer A, Rosenthal LS, Saunders-Pullman R, Scherzer CR, Sherer T, Singleton A, Sutherland M, Thiele I, van der Brug M, Van Keuren-Jensen K, Vaillancourt D, Walt D, West A, Zhang J.

Sci Transl Med. 2018 Aug 15;10(454). pii: eaam6003. doi: 10.1126/scitranslmed.aam6003. Review.

PMID:
30111645
10.

Lessons Learned From a Feasibility Study Delivered in 2 WIC Sites to Promote Physical Activity Among Pregnant Latinas.

Soto SH, Sanz S, Merchant KM, Nichols JF, Arredondo EM.

J Nutr Educ Behav. 2018 Nov - Dec;50(10):1026-1031. doi: 10.1016/j.jneb.2018.04.004. Epub 2018 Jun 25.

PMID:
29954712
11.

Cataract Surgery and Motor Vehicle Fatality Prevention.

Desapriya E, Jhauj R, Merchant K.

JAMA Ophthalmol. 2018 Jul 1;136(7):839. doi: 10.1001/jamaophthalmol.2018.1602. No abstract available.

PMID:
29800010
12.

Cardiovascular Disease Risk in Children With Kidney Disease.

Sethna CB, Merchant K, Reyes A.

Semin Nephrol. 2018 May;38(3):298-313. doi: 10.1016/j.semnephrol.2018.02.009. Review.

PMID:
29753405
13.

Assessment of the Target Engagement and D-Serine Biomarker Profiles of the D-Amino Acid Oxidase Inhibitors Sodium Benzoate and PGM030756.

Howley E, Bestwick M, Fradley R, Harrison H, Leveridge M, Okada K, Fieldhouse C, Farnaby W, Canning H, Sykes AP, Merchant K, Hazel K, Kerr C, Kinsella N, Walsh L, Livermore DG, Hoffman I, Ellery J, Mitchell P, Patel T, Carlton M, Barnes M, Miller DJ.

Neurochem Res. 2017 Nov;42(11):3279-3288. doi: 10.1007/s11064-017-2367-9. Epub 2017 Aug 5.

PMID:
28780732
14.

A user's guide for α-synuclein biomarker studies in biological fluids: Perianalytical considerations.

Mollenhauer B, Batrla R, El-Agnaf O, Galasko DR, Lashuel HA, Merchant KM, Shaw LM, Selkoe DJ, Umek R, Vanderstichele H, Zetterberg H, Zhang J, Caspell-Garcia C, Coffey C, Hutten SJ, Frasier M, Taylor P; Investigating Synuclein Consortium of the Michael J. Fox Foundation for Parkinson's Research.

Mov Disord. 2017 Aug;32(8):1117-1130. doi: 10.1002/mds.27090. Epub 2017 Jul 22. Review.

15.

Air-Abrasive Disinfection of Implant Surfaces in a Simulated Model of Periimplantitis.

Quintero DG, Taylor RB, Miller MB, Merchant KR, Pasieta SA.

Implant Dent. 2017 Jun;26(3):423-428. doi: 10.1097/ID.0000000000000597.

PMID:
28486355
16.

Streamlining Safety Data Collection in Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Trials: Recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project Team.

Donnelly H, Alemayehu D, Botgros R, Comic-Savic S, Eisenstein B, Lorenz B, Merchant K, Pelfrene E, Reith C, Santiago J, Tiernan R, Wunderink R, Tenaerts P, Knirsch C.

Clin Infect Dis. 2016 Aug 15;63 Suppl 2:S39-45. doi: 10.1093/cid/ciw316.

PMID:
27481952
17.

Improving Conduct and Feasibility of Clinical Trials to Evaluate Antibacterial Drugs to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia: Recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project Team.

Knirsch C, Alemayehu D, Botgros R, Comic-Savic S, Friedland D, Holland TL, Merchant K, Noel GJ, Pelfrene E, Reith C, Santiago J, Tiernan R, Tenearts P, Goldsack JC, Fowler VG Jr.

Clin Infect Dis. 2016 Aug 15;63 Suppl 2:S29-36. doi: 10.1093/cid/ciw258.

PMID:
27481950
18.

Effectiveness of the present ROP screening protocol.

Merchant K, Nassar M, Shafiq A, Cottrell D.

Eye (Lond). 2016 Nov;30(11):1524. doi: 10.1038/eye.2016.167. Epub 2016 Jul 29. No abstract available.

19.

Good Clinical Practice Training: Identifying Key Elements and Strategies for Increasing Training Efficiency.

Arango J, Chuck T, Ellenberg SS, Foltz B, Gorman C, Hinrichs H, McHale S, Merchant K, Seltzer J, Shapley S, Wild G.

Ther Innov Regul Sci. 2016 Jul;50(4):480-486. Epub 2016 Mar 11.

20.

Radiologic and histologic presentation of male mammary myofibroblastoma.

Omar LA, Rojanapremsuk T, Saluja K, Merchant KA, Sharma PB.

Proc (Bayl Univ Med Cent). 2016 Jul;29(3):321-2.

21.

Hospital Views of Factors Affecting Telemedicine Use.

Merchant KA, Ward MM, Mueller KJ; Rural Health Research & Policy Centers; Rural Policy Research Institute, RUPRI Center for Rural Health Policy Analysis, University of Iowa College of Public Health, Department of Health Management and Policy.

Rural Policy Brief. 2015 Apr 1;(2015 5):1-4.

PMID:
26793811
22.

Marijuana Use Among Patients With Glaucoma in a City With Legalized Medical Marijuana Use.

Belyea DA, Alhabshan R, Del Rio-Gonzalez AM, Chadha N, Lamba T, Golshani C, Merchant K, Passi N, Dan JA.

JAMA Ophthalmol. 2016 Mar;134(3):259-64. doi: 10.1001/jamaophthalmol.2015.5209.

PMID:
26719907
23.

Transcriptomic Analysis of Induced Pluripotent Stem Cells Derived from Patients with Bipolar Disorder from an Old Order Amish Pedigree.

Kim KH, Liu J, Sells Galvin RJ, Dage JL, Egeland JA, Smith RC, Merchant KM, Paul SM.

PLoS One. 2015 Nov 10;10(11):e0142693. doi: 10.1371/journal.pone.0142693. eCollection 2015.

24.

Respiratory Tract Infection Clinical Trials from 2007 to 2012. A Systematic Review of ClinicalTrials.gov.

Ruopp M, Chiswell K, Thaden JT, Merchant K, Tsalik EL.

Ann Am Thorac Soc. 2015 Dec;12(12):1852-63. doi: 10.1513/AnnalsATS.201505-291OC. Review.

PMID:
26360527
25.

Phosphodiesterase 10A inhibitor, MP-10 (PF-2545920), produces greater induction of c-Fos in dopamine D2 neurons than in D1 neurons in the neostriatum.

Wilson JM, Ogden AM, Loomis S, Gilmour G, Baucum AJ 2nd, Belecky-Adams TL, Merchant KM.

Neuropharmacology. 2015 Dec;99:379-86. doi: 10.1016/j.neuropharm.2015.08.008. Epub 2015 Aug 7.

PMID:
26256420
26.

Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations.

Dehay B, Bourdenx M, Gorry P, Przedborski S, Vila M, Hunot S, Singleton A, Olanow CW, Merchant KM, Bezard E, Petsko GA, Meissner WG.

Lancet Neurol. 2015 Aug;14(8):855-866. doi: 10.1016/S1474-4422(15)00006-X. Epub 2015 Jun 3. Review.

27.

Increased brain bio-distribution and chemical stability and decreased immunogenicity of an engineered variant of GDNF.

Smith RC, O'Bryan LM, Mitchell PJ, Leung D, Ghanem M, Wilson JM, Hanson JC, Sossick S, Cooper J, Huang L, Merchant KM, Lu J, O'Neill MJ.

Exp Neurol. 2015 May;267:165-76. doi: 10.1016/j.expneurol.2015.03.002. Epub 2015 Mar 12.

28.

Evolving toward a human-cell based and multiscale approach to drug discovery for CNS disorders.

Schadt EE, Buchanan S, Brennand KJ, Merchant KM.

Front Pharmacol. 2014 Dec 2;5:252. doi: 10.3389/fphar.2014.00252. eCollection 2014. Review.

29.

Quantitative measurement of intact alpha-synuclein proteoforms from post-mortem control and Parkinson's disease brain tissue by intact protein mass spectrometry.

Kellie JF, Higgs RE, Ryder JW, Major A, Beach TG, Adler CH, Merchant K, Knierman MD.

Sci Rep. 2014 Jul 23;4:5797. doi: 10.1038/srep05797.

30.

Gain and loss of function of P2X7 receptors: mechanisms, pharmacology and relevance to diabetic neuropathic pain.

Ursu D, Ebert P, Langron E, Ruble C, Munsie L, Zou W, Fijal B, Qian YW, McNearney TA, Mogg A, Grubisha O, Merchant K, Sher E.

Mol Pain. 2014 Jun 16;10:37. doi: 10.1186/1744-8069-10-37.

31.

Indirect cyclopexy for treatment of a chronic traumatic cyclodialysis cleft with hypotony.

Chadha N, Lamba T, Belyea DA, Merchant KY.

Clin Ophthalmol. 2014 Mar 22;8:591-4. doi: 10.2147/OPTH.S55938. eCollection 2014.

32.

Pharmacological characterisation of ligand- and voltage-gated ion channels expressed in human iPSC-derived forebrain neurons.

Dage JL, Colvin EM, Fouillet A, Langron E, Roell WC, Li J, Mathur SX, Mogg AJ, Schmitt MG, Felder CC, Merchant KM, Isaac J, Broad LM, Sher E, Ursu D.

Psychopharmacology (Berl). 2014 Mar;231(6):1105-24. doi: 10.1007/s00213-013-3384-2. Epub 2014 Jan 16.

PMID:
24429870
33.

Biomarkers for the development of new medications for cocaine dependence.

Bough KJ, Amur S, Lao G, Hemby SE, Tannu NS, Kampman KM, Schmitz JM, Martinez D, Merchant KM, Green C, Sharma J, Dougherty AH, Moeller FG.

Neuropsychopharmacology. 2014 Jan;39(1):202-19. doi: 10.1038/npp.2013.210. Epub 2013 Aug 27. Review.

34.

Enhanced depth imaging optical coherence tomography of optic nerve head drusen.

Merchant KY, Su D, Park SC, Qayum S, Banik R, Liebmann JM, Ritch R.

Ophthalmology. 2013 Jul;120(7):1409-14. doi: 10.1016/j.ophtha.2012.12.035. Epub 2013 Mar 24.

PMID:
23531353
35.

Structure and clinical significance of central optic disc pits.

Qayum S, Sullivan T, Park SC, Merchant K, Banik R, Liebmann JM, Ritch R.

Ophthalmology. 2013 Jul;120(7):1415-22. doi: 10.1016/j.ophtha.2012.12.034. Epub 2013 Mar 24.

PMID:
23531350
36.

The mGlu2/3 Receptor Agonists LY354740 and LY379268 Differentially Regulate Restraint-Stress-Induced Expression of c-Fos in Rat Cerebral Cortex.

Menezes MM, Santini MA, Benvenga MJ, Marek GJ, Merchant KM, Mikkelsen JD, Svensson KA.

Neurosci J. 2013;2013:736439. doi: 10.1155/2013/736439. Epub 2013 Nov 19.

37.

Deep anterior lamellar corneal dissection to improve visualization during vitreoretinal surgery.

Merchant K, Yewande O, Morgan SJ, Steel DH.

Retina. 2012 Nov-Dec;32(10):2167-70. doi: 10.1097/IAE.0b013e31826a6959. No abstract available.

PMID:
23095729
38.

Measuring the benefit of 4 years of intravitreal ranibizumab treatment for neovascular age-related macular degeneration.

Pushpoth S, Sykakis E, Merchant K, Browning AC, Gupta R, Talks SJ.

Br J Ophthalmol. 2012 Dec;96(12):1469-73. doi: 10.1136/bjophthalmol-2012-302167. Epub 2012 Sep 21.

PMID:
23001255
39.

Mesalazine granules 1.5 g once-daily maintain remission in patients with ulcerative colitis who switch from other 5-ASA formulations: a pooled analysis from two randomised controlled trials.

Lichtenstein GR, Zakko S, Gordon GL, Murthy U, Sedghi S, Pruitt R, Merchant K, Bortey E, Forbes WP.

Aliment Pharmacol Ther. 2012 Jul;36(2):126-34. doi: 10.1111/j.1365-2036.2012.05142.x. Epub 2012 May 23.

40.

Translating glutamate: from pathophysiology to treatment.

Javitt DC, Schoepp D, Kalivas PW, Volkow ND, Zarate C, Merchant K, Bear MF, Umbricht D, Hajos M, Potter WZ, Lee CM.

Sci Transl Med. 2011 Sep 28;3(102):102mr2. doi: 10.1126/scitranslmed.3002804. Review.

41.

Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study.

Sanyal A, Younossi ZM, Bass NM, Mullen KD, Poordad F, Brown RS, Vemuru RP, Mazen Jamal M, Huang S, Merchant K, Bortey E, Forbes WP.

Aliment Pharmacol Ther. 2011 Oct;34(8):853-61. doi: 10.1111/j.1365-2036.2011.04808.x. Epub 2011 Aug 17.

42.

Biochemical and morphological consequences of human α-synuclein expression in a mouse α-synuclein null background.

Prasad K, Tarasewicz E, Strickland PA, O'Neill M, Mitchell SN, Merchant K, Tep S, Hilton K, Datwani A, Buttini M, Mueller-Steiner S, Richfield EK.

Eur J Neurosci. 2011 Feb;33(4):642-56. doi: 10.1111/j.1460-9568.2010.07558.x. Epub 2011 Jan 28.

43.

Clinical trial: once-daily mesalamine granules for maintenance of remission of ulcerative colitis - a 6-month placebo-controlled trial.

Lichtenstein GR, Gordon GL, Zakko S, Murthy U, Sedghi S, Pruitt R, Merchant K, Shaw A, Bortey E, Forbes WP.

Aliment Pharmacol Ther. 2010 Oct;32(8):990-9. doi: 10.1111/j.1365-2036.2010.04438.x. Epub 2010 Aug 18.

44.

Genistein-selenium combination induces growth arrest in prostate cancer cells.

Kumi-Diaka J, Merchant K, Haces A, Hormann V, Johnson M.

J Med Food. 2010 Aug;13(4):842-50. doi: 10.1089/jmf.2009.0199.

PMID:
20553187
45.

Non-basic ligands for aminergic GPCRs: the discovery and development diaryl sulfones as selective, orally bioavailable 5-HT2A receptor antagonists for the treatment of sleep disorders.

Ladduwahetty T, Gilligan M, Humphries A, Merchant KJ, Fish R, McAlister G, Ivarsson M, Dominguez M, O'Connor D, MacLeod AM.

Bioorg Med Chem Lett. 2010 Jun 15;20(12):3708-12. doi: 10.1016/j.bmcl.2010.04.090. Epub 2010 Apr 24.

PMID:
20493697
46.

Rifaximin treatment in hepatic encephalopathy.

Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB, Sigal S, Sheikh MY, Beavers K, Frederick T, Teperman L, Hillebrand D, Huang S, Merchant K, Shaw A, Bortey E, Forbes WP.

N Engl J Med. 2010 Mar 25;362(12):1071-81. doi: 10.1056/NEJMoa0907893.

47.

The Parkinson's disease kinase LRRK2 autophosphorylates its GTPase domain at multiple sites.

Greggio E, Taymans JM, Zhen EY, Ryder J, Vancraenenbroeck R, Beilina A, Sun P, Deng J, Jaffe H, Baekelandt V, Merchant K, Cookson MR.

Biochem Biophys Res Commun. 2009 Nov 20;389(3):449-54. doi: 10.1016/j.bbrc.2009.08.163. Epub 2009 Sep 3.

49.

Caenohabditis elegans in Parkinson's disease drug discovery: addressing an unmet medical need.

Nass R, Merchant KM, Ryan T.

Mol Interv. 2008 Dec;8(6):284-93. doi: 10.1124/mi.8.6.6. Review.

PMID:
19144901
50.

Pakistani urban population demonstrates a poor knowledge about cancers: a pilot survey.

Mazahir S, Nusrat R, Bokutz M, Rizvi NB, Jaffer NN, Malik R, Merchant KA, Raza A, Maqsood M, Hasnain SF, Khawaja MR.

J Cancer Educ. 2008;23(4):264-6. doi: 10.1080/08858190802432984.

PMID:
19058078

Supplemental Content

Loading ...
Support Center